Skip to main content
. 2020 Jul 21;4(4):e424. doi: 10.1097/HS9.0000000000000424

Table 2.

“Add-on” Approaches to Ruxolitinib Being Studied in Ongoing Clinical Trials With Results Available in the Public Domain.

graphic file with name hs9-4-e424-g002.jpg